Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

AstraZeneca, Jacobio Pharma ink pact for proprietary Pan-KRAS inhibitor

AstraZeneca gets global online STARMAP license from Nanoform Finland

Ruchika Sharma26 Oct 2023 2:30 PM IST

Helsinki: Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company has announced that it has granted AstraZeneca Plc a global...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche settles patent lawsuit against Biogen over biosimilar version of rheumatoid arthritis drug Actemra

Ruchika Sharma26 Oct 2023 1:30 PM IST

Basel: Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of...

Bristol Myers Squibb Breyanzi approved by USFDA for adults with Marginal Zone Lymphoma

USFDA grants Breakthrough Therapy Designation for Bristol Myers Squibb BMS-986278 for Progressive Pulmonary Fibrosis

Ruchika Sharma26 Oct 2023 12:30 PM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for...

MSD wins DCGI nod for Keytruda for treatment of triple negative breast cancer, renal cell carcinoma

Ruchika Sharma26 Oct 2023 11:32 AM IST

KEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...

Haridwar: Raid at Golden Life Sciences Company, 3 held

Ruchika Sharma25 Oct 2023 3:05 PM IST

Haridwar: In an attempt to eradicate the attempts of the firms manufacturing pharma products without a valid licence, drug authorities conducted a...

Torrent Pharma reports 24 per cent jump in Q2 net profit

Ruchika Sharma25 Oct 2023 2:30 PM IST

Ahmedabad: Torrent Pharma has reported a 24 per cent jump in its second-quarter net profit after a surge in revenue from India, Brazil and German...

JnJ names Tim Schmid as Executive Vice President, Worldwide Chairman of MedTech

Ruchika Sharma25 Oct 2023 1:30 PM IST

New Brunswick: Johnson & Johnson has announced that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the...

AstraZeneca Imfinzi-based perioperative regimen approved in EU for resectable non-small cell lung cancer

AstraZeneca self-administered nasal flu vaccine accepted for review by USFDA

Ruchika Sharma25 Oct 2023 12:30 PM IST

Cambridge: AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for...

Zydus Lifesciences gets CDSCO nod to begin Phase II clinical trial of ZYIL1 in Amyotrophic Lateral Sclerosis patients

Ruchika Sharma25 Oct 2023 11:16 AM IST

The Phase II clinical trial will study safety, tolerability, pharmacokinetics and pharmacodynamics in patients with ALS.

Expanded age indication for GSK’s AREXVY

GSK, Hansoh Pharma ink pact for HS-20089

Ruchika Sharma24 Oct 2023 3:30 PM IST

Under the terms of this agreement, GSK will pay an USD 85 million upfront payment.

AstraZeneca-Daiichi Sankyo Enhertu approved in EU for lung cancer

Ruchika Sharma24 Oct 2023 1:30 PM IST

Cambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been approved in the European Union (EU) as monotherapy for the...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Roche acquires Telavant Holdings for USD 7.1 billion

Ruchika Sharma24 Oct 2023 12:30 PM IST

Basel: Roche has announced the entry into a definitive agreement to acquire Telavant Holdings, Inc., a Roivant company, owned by Roivant Sciences Ltd....

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok